Other Track AgendasDXS Track One | DXS Track Two |
Thursday, 13 October 201608:00 | Registration & Coffee | 08:45 | Opening Welcome by Lim Chuan Poh, Chairman, A*STAR in the Main Room | 09:00 | Plenary Session in the Main Room | 10:45 | Coffee Break and Networking in Exhibition Area | | Cancer Diagnostics |
| | 11:30 | | 12:00 | The Promise of Liquid Biopsies Across the Continuum of Cancer Care Sarah Ng, Post-doctoral Fellow , IMCB, Singapore
| 12:20 | A Feasibility Study to Detect PD-L1 and PD-L2 on the Surface of Circulating Tumor Cells Using Microfluic-Based Chipcytometry Jinkai Teo, Scientist, Merck, Singapore
| 12:40 | Unveiling the Circulating Tumor-endothelial Cell Cluster Min-Han Tan, Team Leader, Principal Research Scientist, Institute Of Bioengineering & Nanotechnology A*Star, Singapore
| 13:00 | Technology Spotlight: Real Time Dispensing Quality Control for R&D and Production Jeff Chen, Sales Director of SE Asia and Korea, BioDot Inc
| 13:15 | Lunch, Poster Session and Networking in Exhibit Hall | | Next-Generation Sequencing (NGS) for Liquid Biopsy Development and Companion Diagnostics |
| | 14:00 | | Keynote Presentation The Application of Clinical Genomics for Rare Diseases Roger Foo, Group Leader, GIS, Singapore
|
| 14:30 | An Exploration on how Sequencing of Circulating Cell-free RNA in Plasma are Enabling RNA-based Molecules as Clinical Biomarkers Winston Koh, Scientist, Stanford University, United States of America
| 14:50 | Next-generation sequencing as a tool for non-invasive prenatal testing for single gene disorders and aneuploidy Angela Barrett, Research Fellow, National University of Singapore, Singapore
| 15:10 | The Promise of Liquid Biopsies to Precision Medicine Richie Soong, Senior Principle Investigator, National University of Singapore, Singapore
| 15:30 | Coffee Break and Networking in Exhibition Hall | | Circulating Biomarkers vs. Tissue-based Biomarkers for Companion Diagnostics Development |
| | 16:15 | | 17:05 | Molecular Characterization of Circulating Tumor Cells Defines Genetic Signatures for Individualized Cancer Care Say Li Kong, Research Associate, Genome Institute of Singapore, Singapore
| 17:25 | A Novel Blood-based, Host Response Gene Expression Signature for Early Sepsis Siew Hwa Ong, CEO, Acumen Research Laboratories, Singapore
| 17:45 | Hospital-integrated Biobank as an Infrastructure Boosting Diagnostics Discovery and Development Olli Carpen , Professor of Pathology, Scientific Director , University of Helsinki & Helsinki Biobank, Finland
| 18:05 | Drinks Reception & Canapes in the Exhibition Hall | 19:00 | End of Day One |
Friday, 14 October 201608:30 | Registration & Coffee | | Plenary Session |
| | 09:00 | | 09:45 | | Plenary Presentation Funding Landscape in Asia Steven Myint , Senior fellow, Consultant, Adjunct Professor, Chairman, ETPL, Duke-NUS, Inex Private Ltd, Singapore
|
| 10:30 | Coffee Break and Networking in Exhibition Area | | Asia/Pacific vs EU vs US Regulatory Landscape and Barriers to Entry |
| | 11:00 | | Keynote Presentation Regulatory Systems Innovation in the Asia Pacific John CW Lim, Executive Director, Centre of Regulatory Excellence, Duke-NUS Medical School Singapore, Deputy Director of Medical Services (Industry & Research Matters) , Ministry of Health, Singapore
|
| 11:45 | Parallels to Developed Markets as China and Asia Move Forward Nat Whitney, President, Whitney Research, Inc, China
| 12:15 | Europe & USA Medical Device Regulatory Updates Hwee Ee Tan, Principal Consultant/Director, DH RegSys Pte Ltd, Singapore
| 12:45 | Lunch Break and Networking in Exhibition Area | | Novel Diagnostic Tools Session |
| | 14:00 | | Keynote Presentation EFIRM Liquid Biopsy David Wong, Felix and Mildred Yip Endowed Chair in Dentistry; Director for UCLA Center for Oral/Head & Neck Oncology Research, University of California-Los Angeles, United States of America
|
| 14:45 | Development of Blood Based microRNA Tests for Early Detection of Gastric and Breast Cancer Lihan Zhou, Co Founder/Chief Technology Officer, MiRXES Pte Ltd, Singapore
| 15:05 | An Improved Method for Sensitive and High-throughput Quantification of cfDNA in Liquid Biopsy using the Clarity Tube-strip Digital PCR Johnson Ng, Founder And CEO, JN Medsys Pte Ltd, Singapore
| 15:25 | Technology Spotlight: Ultrafast Reversible DNA Photo Cross-Linker 3-Cyanovinylcarbazole Modified Nucleosides from Nicca Takahiro Inatsugi, Assistant Director, Specialty Chemicals Division, Nicca Chemical Co.,Ltd.
| 15:45 | Drinks Reception and Canapes in the Exhibition Area | | Distinguished Technopreneur Speaker Forum | Session Sponsors |
| | 16:30 | Welcome Address by Philip Lim, CE0, ETPL | 16:40 | Presentation of DTS Award by Guest of Honour, Lim Chuan Poh, A*STAR Chairman
The DTS Series was launched in 2008 as part of A*STAR’s initiatives to seed innovation and entrepreneurship in Singapore. The DTS Forum aims to engage the local research and enterprise community – including entrepreneurs, industry professionals, researchers, scholars or students – and inspire them to explore the potential of enterprise based on innovative technologies. Click here for past news on DTS. | 16:50 | | 17:35 | In Conversation with DTS - Discussion Forum - Moderator: Steve Myint , Senior Fellow , A*STAR, Singapore
| 18:00 | Networking and Refreshment |
|